» Articles » PMID: 37345108

Post-Operative Medium- and Long-Term Endocrine Outcomes in Patients with Non-Functioning Pituitary Adenomas-Machine Learning Analysis

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jun 22
PMID 37345108
Authors
Affiliations
Soon will be listed here.
Abstract

Post-operative endocrine outcomes in patients with non-functioning pituitary adenoma (NFPA) are variable. The aim of this study was to use machine learning (ML) models to better predict medium- and long-term post-operative hypopituitarism in patients with NFPAs. We included data from 383 patients who underwent surgery with or without radiotherapy for NFPAs, with a follow-up period between 6 months and 15 years. ML models, including k-nearest neighbour (KNN), support vector machine (SVM), and decision tree models, showed a superior ability to predict panhypopituitarism compared with non-parametric statistical modelling (mean accuracy: 0.89; mean AUC-ROC: 0.79), with SVM achieving the highest performance (mean accuracy: 0.94; mean AUC-ROC: 0.88). Pre-operative endocrine function was the strongest feature for predicting panhypopituitarism within 1 year post-operatively, while endocrine outcomes at 1 year post-operatively supported strong predictions of panhypopituitarism at 5 and 10 years post-operatively. Other features found to contribute to panhypopituitarism prediction were age, volume of tumour, and the use of radiotherapy. In conclusion, our study demonstrates that ML models show potential in predicting post-operative panhypopituitarism in the medium and long term in patients with NFPM. Future work will include incorporating additional, more granular data, including imaging and operative video data, across multiple centres.

Citing Articles

Factors affecting hormonal outcomes in patients undergoing surgery for non-functioning pituitary neuroendocrine tumors: a prospective observational study.

Singh H, Sharma A, Choudhary M, Jain G, Sharma V Neurosurg Rev. 2024; 48(1):4.

PMID: 39725802 DOI: 10.1007/s10143-024-03150-0.


Machine Learning Analysis of Post-Operative Tumour Progression in Non-Functioning Pituitary Neuroendocrine Tumours: A Pilot Study.

Hussein Z, Slack R, Baldeweg S, Mazomenos E, Marcus H Cancers (Basel). 2024; 16(6).

PMID: 38539533 PMC: 10969734. DOI: 10.3390/cancers16061199.

References
1.
Arlt W, Allolio B . Adrenal insufficiency. Lancet. 2003; 361(9372):1881-93. DOI: 10.1016/S0140-6736(03)13492-7. View

2.
Jayasena C, Anderson R, Llahana S, Barth J, MacKenzie F, Wilkes S . Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism. Clin Endocrinol (Oxf). 2021; 96(2):200-219. DOI: 10.1111/cen.14633. View

3.
Fang Y, Wang H, Feng M, Zhang W, Cao L, Ding C . Machine-Learning Prediction of Postoperative Pituitary Hormonal Outcomes in Nonfunctioning Pituitary Adenomas: A Multicenter Study. Front Endocrinol (Lausanne). 2021; 12:748725. PMC: 8529112. DOI: 10.3389/fendo.2021.748725. View

4.
Sherlock M, Ayuk J, Tomlinson J, Toogood A, Aragon-Alonso A, Sheppard M . Mortality in patients with pituitary disease. Endocr Rev. 2010; 31(3):301-42. DOI: 10.1210/er.2009-0033. View

5.
Nomikos P, Ladar C, Fahlbusch R, Buchfelder M . Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas -- a study on 721 patients. Acta Neurochir (Wien). 2004; 146(1):27-35. DOI: 10.1007/s00701-003-0174-3. View